Rituximab is all the rage – and it should be – but it’s not the only immune modulating drug being tested in ME/CFS.
An immune modulating drug trial that recently opened in the Netherlands, of all places, could open new treatment possibilities as well. Because it will finish up before the Rituximab trial it could provide validation of this disease sooner as well.
It also suggests that attitudes are shifting in some surprising places.
Health Rising’s Quickie Summer Donation Drive is On!
Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can.
Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000.
Health Rising’s Quickie Summer Donation Drive is On!
Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can.
Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000.
Why is the Netherlands a strange place – “of all places” – for this to occur? Is there a very imperial attitude at play here that the USA is the “leader of the world”? What’s going on?
Given it’s size, wealth and power the USA is totally underperforming in its contribution to CFS research and advances!
There is no reason to throw around such accusations.
I live in a smaller and much poorer country than Netherlands and I would use the same words as Mr. Johnson.
The prevalent attitude in Netherlands among doctors and researchers has been for years that ME/CFS is a purely psychological disease, so to see a study done on ME/CFS that looks at immune system rather than the psyche, to quote Mr. Johnson, means “attitudes are shifting”
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.
An immune modulating drug trial that recently opened in the Netherlands, of all places, could open new treatment possibilities as well. Because it will finish up before the Rituximab trial it could provide validation of this disease sooner as well.
Health Rising’s Quickie Summer Donation Drive is On!
Why is the Netherlands a strange place – “of all places” – for this to occur? Is there a very imperial attitude at play here that the USA is the “leader of the world”? What’s going on?
Given it’s size, wealth and power the USA is totally underperforming in its contribution to CFS research and advances!
There is no reason to throw around such accusations.
I live in a smaller and much poorer country than Netherlands and I would use the same words as Mr. Johnson.
The prevalent attitude in Netherlands among doctors and researchers has been for years that ME/CFS is a purely psychological disease, so to see a study done on ME/CFS that looks at immune system rather than the psyche, to quote Mr. Johnson, means “attitudes are shifting”